TARGETING GLUTAMINE METABOLISM AS A THERAPEUTIC STRATEGY IN MYC-DRIVEN MEDULLOBLASTOMA

被引：0
|
作者：
Hanaford, Allison [1 ]
Eberhart, Charles [1 ]
Archer, Tenley [3 ]
Tamayo, Pablo [4 ]
Pomeroy, Scott [3 ]
Raabe, Eric [2 ]
机构：
[1] Johns Hopkins Sch Med, Baltimore, MD USA
[2] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA
[3] Boston Childrens Hosp, Cambrdige, MA USA
[4] Eli & Edythe Broad Inst MIT & Harvard Univ, Cambrdige, MA USA
来源：
NEURO-ONCOLOGY | 2014年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MB-091
引用
收藏
页码：94 / 94
页数：1
相关论文
共 50 条
  • [21] Targeting glutamine metabolism as a therapeutic strategy for cancer
    Jonghwa Jin
    Jun-Kyu Byun
    Yeon-Kyung Choi
    Keun-Gyu Park
    Experimental & Molecular Medicine, 2023, 55 : 706 - 715
  • [22] Interrogating the function of histone methyltransferases in MYC-driven medulloblastoma
    Mercier, Audrey L.
    Stripay, Jennifer L.
    Bilokapic, Silvij A.
    Williams, Justin
    Nance, Stephanie
    Liu, Jingjing
    Philips, Steven
    Kandikonda, Suresh
    Morfouace, Marie
    Bramoulle, Aude
    Advedissian, Tamara
    Yu, Jiyang
    Peng, Junmin
    Ansari, Aseem
    Halic, Mario
    Durbin, Adam
    Vakoc, Christopher
    Roussel, Martine F.
    CANCER RESEARCH, 2022, 82 (12)
  • [23] Therapeutic targeting of MYC-driven prostate cancer by PIM kinase inhibition
    Abdulkadir, Sarki
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2016, 38 : S7 - S7
  • [24] PCYT1A in MYC-Driven Lymphoma: Role on Aberrant Choline Metabolism and Therapeutic Targeting By Berberine
    Xiong, Jie
    Wang, Li
    Zhao, Weili
    BLOOD, 2015, 126 (23)
  • [25] The role of PRMT5 in MYC-driven medulloblastoma
    Chaturvedi, Nagendra K.
    Kesherwani, Varun
    Kling, Matthew J.
    Ray, Sutapa
    McGuire, Timothy R.
    Joshi, Shantaram S.
    Sharp, J. Graham
    Coulter, Don W.
    CANCER RESEARCH, 2019, 79 (13)
  • [26] Unveiling the immune landscape of recurrent, MYC-driven medulloblastoma
    Draper, Ben
    Thompson, Dean
    Morcavallo, Alaide
    Remeniuk, Bethany
    Anderson, John
    Chesler, Louis
    Ord, Steve Cli Overline
    Huang, Frank
    Donovan, Laura K.
    CANCER RESEARCH, 2024, 84 (17)
  • [27] THE ROLE OF WEE1 IN Myc-DRIVEN MEDULLOBLASTOMA
    Moreira, Daniel
    Venkataraman, Sujatha
    Balakrishnan, Ilango
    Prince, Eric
    Foreman, Nicholas
    Vibhakar, Rajeev
    NEURO-ONCOLOGY, 2016, 18 : 113 - 113
  • [28] INTERROGATING THE ROLE OF EPIGENETIC REGULATORS IN MYC-DRIVEN MEDULLOBLASTOMA
    Stripay, Jennifer
    Morfouace, Marie
    Vakoc, Christopher
    Roussel, Martine
    NEURO-ONCOLOGY, 2019, 21 : 108 - 108
  • [29] Therapeutic targets for MYC-driven cancers
    Laffman-Johnson, Elise
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 92 (03) : 272 - 272
  • [30] Novel Glutamine Antagonist JHU395 Suppresses MYC-Driven Medulloblastoma Growth and Induces Apoptosis
    Pham, Khoa
    Maxwell, Micah J.
    Sweeney, Heather
    Alt, Jesse
    Rais, Rana
    Eberhart, Charles G.
    Slusher, Barbara S.
    Raabe, Eric H.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2021, 80 (04): : 336 - 344
12345